This study hypothesized that the Th17/Th1 pathway, driven by β2GPI, plays a significant role in the inflammation and potential atherothrombotic events in patients with SLE and APS, highlighting a critical interaction between IL-17, Th17 cells, and β2GPI. Here, IL17A is linked to systemic lupus erythematosus.